- Home
- TXMD vs LMFA Comparison
TXMD vs LMFA Comparison
Compare TXMD & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- LMFA
- Stock Information
- Founded
- TXMD 2008
- LMFA 2008
- Country
- TXMD United States
- LMFA United States
- Employees
- TXMD N/A
- LMFA N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- LMFA Finance: Consumer Services
- Sector
- TXMD Health Care
- LMFA Finance
- Exchange
- TXMD Nasdaq
- LMFA Nasdaq
- Market Cap
- TXMD 12.7M
- LMFA 11.9M
- IPO Year
- TXMD N/A
- LMFA 2015
- Fundamental
- Price
- TXMD $1.07
- LMFA $1.09
- Analyst Decision
- TXMD
- LMFA Strong Buy
- Analyst Count
- TXMD 0
- LMFA 1
- Target Price
- TXMD N/A
- LMFA $5.00
- AVG Volume (30 Days)
- TXMD 17.2K
- LMFA 613.3K
- Earning Date
- TXMD 08-12-2025
- LMFA 08-14-2025
- Dividend Yield
- TXMD N/A
- LMFA N/A
- EPS Growth
- TXMD N/A
- LMFA N/A
- EPS
- TXMD N/A
- LMFA N/A
- Revenue
- TXMD $2,559,000.00
- LMFA $6,755,925.00
- Revenue This Year
- TXMD $427.09
- LMFA N/A
- Revenue Next Year
- TXMD N/A
- LMFA $6.50
- P/E Ratio
- TXMD N/A
- LMFA N/A
- Revenue Growth
- TXMD 156.93
- LMFA N/A
- 52 Week Low
- TXMD $0.70
- LMFA $1.02
- 52 Week High
- TXMD $2.44
- LMFA $5.14
- Technical
- Relative Strength Index (RSI)
- TXMD 42.48
- LMFA 32.62
- Support Level
- TXMD $1.05
- LMFA $1.04
- Resistance Level
- TXMD $1.12
- LMFA $1.34
- Average True Range (ATR)
- TXMD 0.04
- LMFA 0.12
- MACD
- TXMD -0.00
- LMFA -0.03
- Stochastic Oscillator
- TXMD 15.46
- LMFA 3.78
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.